Ranibizumab and Reduced Fluence PDT for AMD

Clinical trial NCT00527475 · COMPLETED

Trial details

NCT number: NCT00527475
Sponsor: Texas Retina Associates
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Macular Degeneration

Start date: 2007-05-01
Primary completion: 2010-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.